Adar Poonawalla

Indian businessman

Adar Poonawalla ▸ Facts ▸ Comments ▸ News ▸ Videos

Adar Poonawalla is the chief executive officer (CEO) of Serum Institute of India. Founded in 1966 by his father, Cyrus Poonawalla, it is the world's largest vaccine manufacturer by number of doses produced.

0 shares	Share Tweet Save Post Send


Lucknow man files complaint against Adar Poonawalla for 'no antibodies' despite jab \| Oneindia News A man in Lucknow has filed a complaint against Serum Institute of India CEO Adar Poonawalla and others, alleging that he did not develop antibodies despite taking a Covishield dose. The complaint has.. Credit: Oneindia Duration: 01:48Published 3 weeks ago

Covid recoveries more than daily active cases \| Highest single-day death: 4,329 \| Oneindia News Serum Institute CEO Adar Poonawalla said that SII has “never exported vaccines at the cost of the people of India"; A vessel with 273 personnel on board, which was stranded near Bombay High during.. Credit: Oneindia Duration: 03:00Published on May 18, 2021


Watch: Congress responds to Adar Poonawalla’s ‘being threatened’ charge Maharashtra Congress Chief chief Nana Patole has responded to SII chief Adar Poonawalla’s allegation that he is being threatened. Addressing the media, Patole said that Congress is worried over.. Credit: HT Digital Content Duration: 02:05Published on May 3, 2021

Who threatened him?, asks Nana Patole on Adar Poonawalla's threat claims During an interview to a London newspaper, head of Serum Institute of India (SII) Adar Poonawalla, who is one of the vaccine manufacturers in India, revealed that he is receiving threats from big.. Credit: ANI Duration: 01:36Published on May 3, 2021

‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls Serum Institute of India CEO Adar Poonawalla, who has been in the UK on extended stay to evade alleged threats in India over ever-increasing demand for COVID-19 vaccines, has said he will return in a.. Credit: HT Digital Content Duration: 01:50Published on May 2, 2021

‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India Serum Institute of India CEO Adar Poonawalla on Saturday spoke out about the pressures he was under over the production of COVID-19 vaccines to meet the ever-increasing demand in India as the country.. Credit: HT Digital Content Duration: 01:43Published on May 1, 2021

Adar Poonawalla 'life threat' \| SII CEO gets Y security cover \| Oneindia News Amid threats to his life over Covishield vaccine supplies, the CEO of Serum Institute of India, the world's largest vaccine maker, has got Y category security. The centre granted SII CEO Adar.. Credit: Oneindia Duration: 01:30Published on April 29, 2021

Covid: SII reduces Covishield price, vaccine now at Rs 300 per dose for states Serum Institute of India reduced the vaccine price for the state government from Rs 400 per dose to Rs 300 per dose. SII chairman Adar Poonawalla announced on Twitter a reduction in prices... Credit: HT Digital Content Duration: 01:27Published on April 28, 2021

You Might Like

Poonawalla tells Bombay HC he seeks no Z-Plus cover, nor endorses any plea on his behalf; petition disposed IndiaTimes - Published 2 weeks ago
Poonawalla thanks Biden, Jaishankar for policy change to boost vaccine production IndiaTimes - Published 3 weeks ago
Covid-19: Didn't export vaccines at the cost of the people in India, says Adar Poonawalla IndiaTimes - Published on May 18, 2021

Serum Institute CEO Adar Poonawalla finally breaks silence on export of vaccines "Our government extended support wherever possible during this period," Serum Institute said in a statement. DNA - Published on May 18, 2021
Plea in Bombay HC seeks Z-plus security for SII CEO Adar Poonawalla IndiaTimes - Published on May 6, 2021
Not possible to ramp up vaccine production overnight: SII CEO Adar Poonawala Serum Institute of India (SII) CEO Adar Poonawala on Monday said it is not possible to ramp up vaccine production overnight.Amid the ferocious second wave gripping India, Poonawala said "vaccine.. IndiaTimes - Published on May 3, 2021

Congress assures security to Adar Poonawalla, urges him to name leaders who made threat calls Maharashtra Congress chief Nana Patole urged Poonawalla to make the names of those leaders public, adding that his party takes full responsibility for his security. IndiaTimes - Published on May 3, 2021
Serum Institute of India CEO Adar Poonawalla makes BIG statement over COVID-19 vaccine shortage According to a Financial Times report, SII CEO said that production of vaccines would increase in July from about 60-70 million to 100mln per month. DNA - Published on May 3, 2021
Serum Institute CEO Adar Poonawalla: Will return to India in a few days "Had an excellent meeting with all our partners & stakeholders in the UK. Meanwhile, pleased to state that Covishiled's production is in full swing in Pune. I look forward to reviewing operations upon.. IndiaTimes - Published on May 2, 2021
Serum Institute of India CEO Adar Poonawalla flies to London to after receiving 'threats' from CMs, corporates leaders Poonawalla said that he is planning to stay in the UK for a long time because of constant threats he's getting from CMs and other corporate leaders. DNA - Published on May 2, 2021

Covishield production in full swing, says SII's Adar Poonawalla IndiaTimes - Published on May 2, 2021
'Getting aggressive calls from powerful people': Serum CEO Adar Poonawalla on vaccine pressure Referring to the phone calls, Poonawala said "Threats is an understatement. The level of expectation and aggression is really unprecedented. It's overwhelming. Everyone feels they should get the.. IndiaTimes - Published on May 1, 2021
Serum Institute plans to start Covid vaccine production outside India: Report The Serum Institute of India, which manufactures the AstraZeneca Covid-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief.. IndiaTimes - Published on May 1, 2021	Serum Institute CEO Adar Poonawalla gets 'Y' category security cover IndiaTimes - Published on April 28, 2021
Serum Institute reduces Covishield price for states from Rs 400 to Rs 300 per dose Serum Institute of India on Wednesday announced that it was reducing the price of its Covishield vaccine from Rs 400 to Rs 300 per dose for the states as a "philanthropic gesture". "As a philanthropic.. IndiaTimes - Published on April 28, 2021	Covid-19: Most vaccines may cost 700-1,000 per dose Most companies are expected to price the Covid-19 vaccines around Rs 700-1,000 per dose, when they roll out the jabs in the private market later this year, up from the government-mandated price of Rs.. IndiaTimes - Published on April 20, 2021
Covovax trials begin in India, hope to launch it by Sept 2021: Adar Poonawalla Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said clinical trials of Covid-19 vaccine Covovax have begun in India and the company hopes to launch it by September this year. IndiaTimes - Published on March 27, 2021	Adar Poonawalla urges countries to be patient, says Serum directed to prioritise India needs Adar Poonawalla, CEO of vaccine major Serum Institute of India (SII), on Sunday urged other countries to be patient as they wait for the supplies of Covid-19 vaccine, Covishield, as the company has.. IndiaTimes - Published on February 21, 2021
India's Serum says will ship AstraZeneca vaccine to Canada in 'less than a month' The Serum Institute of India will ship the Oxford University/AstraZeneca Covid-19 vaccine to Canada in less than one month, Serum's chief executive said on Monday. "As we await regulatory approvals.. IndiaTimes - Published on February 15, 2021	Serum Institute of India plans to launch Covovax by June: Adar Poonawalla SII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We have applied for starting trials in India. Hope to launch.. IndiaTimes - Published on January 30, 2021
COVID-19: Is India to get one more coronavirus vaccine, here's what SII CEO Adar Poonawalla said The vaccine is being developed in partnership with American vaccine developer Novavax. DNA - Published on January 30, 2021	Serum Institute applies to conduct local trial for Novavax vaccine: CEO The Serum Institute of India (SII), the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc's COVID-19 vaccine, which was found to be 89.3%.. IndiaTimes - Published on January 29, 2021
SII to send 3m Covid shots to Saudi in a week: Poonawalla IndiaTimes - Published on January 26, 2021	Serum fire losses pegged at over Rs 1,000 crore; Covid vaccine supplies safe Serum Institute of India (SII) CEO Adar Poonawalla on Friday said its manufacturing plant at Manjari here suffered a loss of over Rs1,000 crore in Thursday’s fire that claimed five lives. IndiaTimes - Published on January 22, 2021
Serum Institute fire: Vaccine supply won't be affected, says CEO Adar Poonawalla IndiaTimes - Published on January 22, 2021	Serum Institute fire: Adar Poonawalla explains why he tweeted, 'no lives lost' Adar Poonawalla has given an explanation on his tweet that he did after fire broke out at Serum Institute's facility in Pune on Thursday afternoon. DNA - Published on January 22, 2021
Adar Poonawalla reassures Covishield production won't be affected, tweets 'no lives lost' in SII fire A major fire broke out at a building inside Terminal Gate 1 of the Serum Institute of India (SII) in Maharashtra's Pune on Thursday afternoon. DNA - Published on January 21, 2021	COVID-19: Serum Institute CEO Adar Poonawalla reveals cost of Covishield vaccine in private markets - Check price here Serum Institute of India CEO Adar Poonawalla on Tuesday (January 12) said that 'Covishield' will be made available in private markets at Rs 1,000. DNA - Published on January 12, 2021
Covishield to cost Rs 1000 per vial in private market: SII CEO Adar Poonawalla "We have given a special price of Rs 200 for the first 100 million doses only to the Government of India on their request, because we want to support common man, vulnerable, poor and healthcare.. IndiaTimes - Published on January 12, 2021	Brazil dials India on Covid vaccine imports India’s vaccine diplomacy push might be impacted by confusing signals on the export of vaccines. On Monday, the Jair Bolsonaro government in Brazil dialled the Indian government after the chief of.. IndiaTimes - Published on January 6, 2021
Private hospitals, companies may get vaccine by March: Serum CEO SII, once it rolls out the 50-60 million doses of Covishield that forms the first tranche of the govt's order, will give doses to private individuals, private hospitals and companies as early as March,.. IndiaTimes - Published on January 4, 2021	COVID-19 vaccine manufacturers must be protected from lawsuits: SII CEO Adar Poonawalla Poonawalla made these comments at an online panel on the challenges of developing a COVID-19 vaccine at the Carnegie India's Global Technology Summit DNA - Published on December 20, 2020
Govt must indemnify vaccine makers against all lawsuits: Adar Poonawalla IndiaTimes - Published on December 19, 2020	SII CEO thanks PM Modi for support after seeking emergency authorisation of its Covid vaccine After Serum Institute India (SII) applied for the emergency use authorisation of its coronavirus vaccine "COVISHIELD", its CEO Adar Poonawala expressed gratitude to Prime Minister Narendra Modi and the.. IndiaTimes - Published on December 7, 2020
COVID-19 'Virus Busters': Serum Insititute of India's Adar Poonawalla among six named 'Asians of The Year' Poonawala joined the Serum Institute of India in 2001 and took over the day-to-day operations of the company as CEO in 2011. DNA - Published on December 5, 2020	Formed task force in Maha to manage COVID vaccine distribution; in touch with Serum CEO: Thackeray to PM Modi Maharashtra is in touch with Adar Poonawalla, CEO of Serum Institute of India, for coronavirus vaccine, CM Uddhav Thackeray told PM Modi. DNA - Published on November 24, 2020
Covid vaccine should be available for public by April 2021: Serum Institute CEO Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford Covid-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by.. IndiaTimes - Published on November 20, 2020	India to get 100 million doses of Oxford COVID-19 vaccine by Dec, says Adar Poonawalla SII, which has tied up with five developers, has so far made 40 million doses of AstraZeneca vaccine in the past two months and aims to start manufacturing Novavax's contender soon. DNA - Published on November 14, 2020
Vaccine may be ready for use as early as December: Adar Poonawalla IndiaTimes - Published on October 29, 2020	I wish government's Covid vaccine strategy was 'Mann ki Baat': Rahul Gandhi Gandhi's tweet came after Prime Minister Narendra Modi aired his monthly 'Mann ki baat' programme on the All India Radio (AIR). Along with his comment, Gandhi shared a news report regarding Serum.. IndiaTimes - Published on September 27, 2020
Applaud PM's vision on providing vaccines to global community: Serum's Adar Poonawalla IndiaTimes - Published on September 27, 2020	Govt will need 80,000 crore for Covid vaccine, says Serum CEO The government may need Rs 80,000 crore over the next one year for distribution of Covid-19 vaccine and immunization of the country’s population, Adar Poonawalla, CEO and promoter of the world’s.. IndiaTimes - Published on September 26, 2020
Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla asks On September 16, the Drugs Controller General of India (DCGI) allowed the Serum Institute of India (SII) to restart its phase two and three clinical trials for the Oxford-AstraZeneca COVID-19 vaccine. DNA - Published on September 26, 2020	Covid-19 vaccine by October-November: Adar Poonawalla to Naveen Patnaik Adar Poonawalla, during an interaction with Odisha chief minister Naveen Patnaik through a video conference, expressed optimism that the Covid-19 vaccine could be ready by October-November this year.. IndiaTimes - Published on July 22, 2020

Adar Poonawalla

Indian businessman

Adar Poonawalla ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

Poonawalla tells Bombay HC he seeks no Z-Plus cover, nor endorses any plea on his behalf; petition disposed

Poonawalla thanks Biden, Jaishankar for policy change to boost vaccine production

Covid-19: Didn't export vaccines at the cost of the people in India, says Adar Poonawalla

Serum Institute CEO Adar Poonawalla finally breaks silence on export of vaccines

Plea in Bombay HC seeks Z-plus security for SII CEO Adar Poonawalla

Not possible to ramp up vaccine production overnight: SII CEO Adar Poonawala

Congress assures security to Adar Poonawalla, urges him to name leaders who made threat calls

Serum Institute of India CEO Adar Poonawalla makes BIG statement over COVID-19 vaccine shortage

Serum Institute CEO Adar Poonawalla: Will return to India in a few days

Serum Institute of India CEO Adar Poonawalla flies to London to after receiving 'threats' from CMs, corporates leaders

Covishield production in full swing, says SII's Adar Poonawalla

'Getting aggressive calls from powerful people': Serum CEO Adar Poonawalla on vaccine pressure

Serum Institute plans to start Covid vaccine production outside India: Report

Serum Institute CEO Adar Poonawalla gets 'Y' category security cover

Serum Institute reduces Covishield price for states from Rs 400 to Rs 300 per dose

Covid-19: Most vaccines may cost 700-1,000 per dose

Covovax trials begin in India, hope to launch it by Sept 2021: Adar Poonawalla

Adar Poonawalla urges countries to be patient, says Serum directed to prioritise India needs

India's Serum says will ship AstraZeneca vaccine to Canada in 'less than a month'

Serum Institute of India plans to launch Covovax by June: Adar Poonawalla

COVID-19: Is India to get one more coronavirus vaccine, here's what SII CEO Adar Poonawalla said

Serum Institute applies to conduct local trial for Novavax vaccine: CEO

SII to send 3m Covid shots to Saudi in a week: Poonawalla

Serum fire losses pegged at over Rs 1,000 crore; Covid vaccine supplies safe

Serum Institute fire: Vaccine supply won't be affected, says CEO Adar Poonawalla

Serum Institute fire: Adar Poonawalla explains why he tweeted, 'no lives lost'

Adar Poonawalla reassures Covishield production won't be affected, tweets 'no lives lost' in SII fire

COVID-19: Serum Institute CEO Adar Poonawalla reveals cost of Covishield vaccine in private markets - Check price here

Covishield to cost Rs 1000 per vial in private market: SII CEO Adar Poonawalla

Brazil dials India on Covid vaccine imports

Private hospitals, companies may get vaccine by March: Serum CEO

COVID-19 vaccine manufacturers must be protected from lawsuits: SII CEO Adar Poonawalla

Govt must indemnify vaccine makers against all lawsuits: Adar Poonawalla

SII CEO thanks PM Modi for support after seeking emergency authorisation of its Covid vaccine

COVID-19 'Virus Busters': Serum Insititute of India's Adar Poonawalla among six named 'Asians of The Year'

Formed task force in Maha to manage COVID vaccine distribution; in touch with Serum CEO: Thackeray to PM Modi

Covid vaccine should be available for public by April 2021: Serum Institute CEO

India to get 100 million doses of Oxford COVID-19 vaccine by Dec, says Adar Poonawalla

Vaccine may be ready for use as early as December: Adar Poonawalla

I wish government's Covid vaccine strategy was 'Mann ki Baat': Rahul Gandhi

Applaud PM's vision on providing vaccines to global community: Serum's Adar Poonawalla

Govt will need 80,000 crore for Covid vaccine, says Serum CEO

Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla asks

Covid-19 vaccine by October-November: Adar Poonawalla to Naveen Patnaik